
New FDA Approval: QLOSI
We’re excited to announce a major development in treating presbyopia, a common age-related condition affecting close object focus. The U.S. FDA has approved QLOSI™ (pilocarpine hydrochloride [...]
We’re excited to announce a major development in treating presbyopia, a common age-related condition affecting close object focus. The U.S. FDA has approved QLOSI™ (pilocarpine hydrochloride [...]
Exploring Advanced Pediatric Eye Care with Compton Eye Associates At Compton Eye Associates, we go beyond the early stages of baby vision development, diving deeper into the ongoing journey of [...]
Are you struggling with age-related vision changes, especially presbyopia? You’re not alone. Presbyopia, a natural part of aging, often leads to difficulty in reading small print and seeing [...]
In a significant health alert, the FDA has issued a warning and subsequent recalls for several major brands of eye drops. This action comes in response to the discovery of insanitary conditions [...]